These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32435362)

  • 1. Sulfonimide and Amide Derivatives as Novel PPARα Antagonists: Synthesis, Antiproliferative Activity, and Docking Studies.
    Ammazzalorso A; Bruno I; Florio R; De Lellis L; Laghezza A; Cerchia C; De Filippis B; Fantacuzzi M; Giampietro L; Maccallini C; Tortorella P; Veschi S; Loiodice F; Lavecchia A; Cama A; Amoroso R
    ACS Med Chem Lett; 2020 May; 11(5):624-632. PubMed ID: 32435362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, in vitro evaluation, and molecular modeling investigation of benzenesulfonimide peroxisome proliferator-activated receptors α antagonists.
    Ammazzalorso A; Carrieri A; Verginelli F; Bruno I; Carbonara G; D'Angelo A; De Filippis B; Fantacuzzi M; Florio R; Fracchiolla G; Giampietro L; Giancristofaro A; Maccallini C; Cama A; Amoroso R
    Eur J Med Chem; 2016 May; 114():191-200. PubMed ID: 26974385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of PPARα inhibition in head and neck paraganglioma cells.
    Florio R; De Lellis L; di Giacomo V; Di Marcantonio MC; Cristiano L; Basile M; Verginelli F; Verzilli D; Ammazzalorso A; Prasad SC; Cataldi A; Sanna M; Cimini A; Mariani-Costantini R; Mincione G; Cama A
    PLoS One; 2017; 12(6):e0178995. PubMed ID: 28594934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel structural class of coumarin-chalcone fibrates as PPARα/γ agonists with potent antioxidant activities: Design, synthesis, biological evaluation and molecular docking studies.
    Niu H; Wang W; Li J; Lei Y; Zhao Y; Yang W; Zhao C; Lin B; Song S; Wang S
    Eur J Med Chem; 2017 Sep; 138():212-220. PubMed ID: 28667876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing Effects of PPARα Agonism and Antagonism on Refractive Development and Form Deprivation Myopia in Guinea Pigs.
    Pan M; Jiao S; Reinach PS; Yan J; Yang Y; Li Q; Srinivasalu N; Qu J; Zhou X
    Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5803-5815. PubMed ID: 30521668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Phenyldiazenyl Fibrate Analogues as PPAR α/γ/δ Pan-Agonists for the Amelioration of Metabolic Syndrome.
    Giampietro L; Laghezza A; Cerchia C; Florio R; Recinella L; Capone F; Ammazzalorso A; Bruno I; De Filippis B; Fantacuzzi M; Ferrante C; Maccallini C; Tortorella P; Verginelli F; Brunetti L; Cama A; Amoroso R; Loiodice F; Lavecchia A
    ACS Med Chem Lett; 2019 Apr; 10(4):545-551. PubMed ID: 30996794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of new RAF kinase-inhibiting antiproliferative quinoline derivatives. Part 2: Diarylurea derivatives.
    El-Gamal MI; Khan MA; Tarazi H; Abdel-Maksoud MS; Gamal El-Din MM; Yoo KH; Oh CH
    Eur J Med Chem; 2017 Feb; 127():413-423. PubMed ID: 28088086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Target Prediction Analysis.
    Amoroso R; De Lellis L; Florio R; Moreno N; Agamennone M; De Filippis B; Giampietro L; Maccallini C; Fernández I; Recio R; Cama A; Fantacuzzi M; Ammazzalorso A
    Pharmaceuticals (Basel); 2022 Jul; 15(8):. PubMed ID: 36015085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular determinants for improved activity at PPARα: structure-activity relationship of pirinixic acid derivatives, docking study and site-directed mutagenesis of PPARα.
    Lamers C; Dittrich M; Steri R; Proschak E; Schubert-Zsilavecz M
    Bioorg Med Chem Lett; 2014 Aug; 24(16):4048-52. PubMed ID: 25022880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of novel benzothiazole amides: Evaluation of PPAR activity and anti-proliferative effects in paraganglioma, pancreatic and colorectal cancer cell lines.
    Ammazzalorso A; De Lellis L; Florio R; Laghezza A; De Filippis B; Fantacuzzi M; Giampietro L; Maccallini C; Tortorella P; Veschi S; Loiodice F; Cama A; Amoroso R
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2302-2306. PubMed ID: 31272790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, broad-spectrum antiproliferative activity, and kinase inhibitory effect of triarylpyrazole derivatives possessing arylamides or arylureas moieties.
    Gamal El-Din MM; El-Gamal MI; Abdel-Maksoud MS; Yoo KH; Oh CH
    Eur J Med Chem; 2016 Aug; 119():122-31. PubMed ID: 27155467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, in-vitro antiproliferative activity and kinase profile of new picolinamide based 2-amido and ureido quinoline derivatives.
    El-Damasy AK; Seo SH; Cho NC; Kang SB; Pae AN; Kim KS; Keum G
    Eur J Med Chem; 2015 Aug; 101():754-68. PubMed ID: 26218653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, in silico toxicity prediction, molecular docking, and evaluation of novel pyrazole derivatives as potential antiproliferative agents.
    Ravula P; Vamaraju HB; Paturi M; Chandra Jn NS; Kolli S
    EXCLI J; 2016; 15():187-202. PubMed ID: 27103897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antiproliferative activity of amino-substituted benzimidazo[1,2-α]quinolines as mesylate salts designed by 3D-QSAR analysis.
    Vušak D; Perin N; Martin-Kleiner I; Kralj M; Karminski-Zamola G; Hranjec M; Bertoša B
    Mol Divers; 2017 Aug; 21(3):621-636. PubMed ID: 28667495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and molecular docking of novel N,N-dimethylbenzenesulfonamide derivatives as potential antiproliferative agents.
    Bashandy MS; Alsaid MS; Arafa RK; Ghorab MM
    J Enzyme Inhib Med Chem; 2014 Oct; 29(5):619-27. PubMed ID: 24090422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and molecular docking of amide and urea derivatives as Escherichia coli PDHc-E1 inhibitors.
    He JB; Ren YL; Sun QS; You GY; Zhang L; Zou P; Feng LL; Wan J; He HW
    Bioorg Med Chem; 2014 Jun; 22(12):3180-6. PubMed ID: 24800939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Biological Evaluation of Novel Triple-Modified Colchicine Derivatives as Potent Tubulin-Targeting Anticancer Agents.
    Majcher U; Klejborowska G; Kaik M; Maj E; Wietrzyk J; Moshari M; Preto J; Tuszynski JA; Huczyński A
    Cells; 2018 Nov; 7(11):. PubMed ID: 30463236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of Naphthyl-, Quinolin- and Anthracenyl Analogues of Clofibric Acid as PPARα Agonists.
    Giampietro L; Ammazzalorso A; Bruno I; Carradori S; De Filippis B; Fantacuzzi M; Giancristofaro A; Maccallini C; Amoroso R
    Chem Biol Drug Des; 2016 Mar; 87(3):467-71. PubMed ID: 26502898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-Scale Screening of Natural Products Transactivating Peroxisome Proliferator-Activated Receptor α Identifies 9S-Hydroxy-10E,12Z,15Z-Octadecatrienoic Acid and Cymarin as Potential Compounds Capable of Increasing Apolipoprotein A-I Transcription in Human Liver Cells.
    van der Krieken SE; Popeijus HE; Bendik I; Böhlendorf B; Konings MCJM; Tayyeb J; Mensink RP; Plat J
    Lipids; 2018 Nov; 53(11-12):1021-1030. PubMed ID: 30706477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biphenyl derivatives incorporating urea unit as novel VEGFR-2 inhibitors: design, synthesis and biological evaluation.
    Wang C; Gao H; Dong J; Zhang Y; Su P; Shi Y; Zhang J
    Bioorg Med Chem; 2014 Jan; 22(1):277-84. PubMed ID: 24315192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.